Combination of Serum KL-6 and Immune/Inflammatory Markers for Identifying Complicated Silicosis

• by Rui He, Limin Huang, Yang Chen, Minqi Liu, Miaomiao Xie, Honglei Yuan, Ling Mao

• January 3, 2026

Botulinum Toxin Evaluated in Digital Ischemia

Individual-level meta-analysis examines response, dosing, and safety across ischemic etiologies

• by Kathryn Wighton

• April 3, 2026

• 3 min

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.

• by Kathryn Wighton

• May 29, 2026

• 3 min

GLP-1 Drugs Linked to GI Effects, Uncertain Signals

Umbrella review evaluates over 1,700 trials to assess noncardiometabolic outcomes beyond weight and glycemic effects.

• by Kathryn Wighton

• April 16, 2026

• 3 min